Showing results (191-200 of 248) with videos related to

Sort By:
Pageof 25
Oncotarget|April 24, 2018
Prognostic value of early 18F-FDG PET scanning evaluation in immunocompetent primary CNS lymphoma patientsRudy Birsen, Estelle Blanc, Lise Willems, et al.
Neuropathology and Applied Neurobiology|March 16, 2022
Rosette-forming glioneuronal tumours are midline, FGFR1-mutated tumoursRomain Appay, Franck Bielle, Philipp Sievers, et al.
Neuro-Oncology|April 14, 2026
CNS tumor type prevalence according to age group: an analysis of 21,000 cases confirmed by methylation profiling, with a focus on adolescents and young adultsAdriana Fonseca, Leeor Yefet, Omkar Singh, et al.
Brain Communications|November 11, 2025
Clinical and molecular landscape of paediatric cerebral and spinal cavernous malformationsSandro Benichi, Estelle Balducci, Joseph Benzakoun, et al.
The American Journal of Surgical Pathology|May 17, 2012
Histopathologic and ultrastructural features and claudin expression in papillary tumors of the pineal region: a multicenter analysisMichelle Fèvre Montange, Alexandre Vasiljevic, Anne-Marie Bergemer Fouquet, et al.
Plos One|February 8, 2011
Clinical relevance of tumor cells with stem-like properties in pediatric brain tumorsCécile Thirant, Barbara Bessette, Pascale Varlet, et al.
Neuro-Oncology|March 14, 2023
Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA studyRebecca J Chapman, David R Ghasemi, Felipe Andreiuolo, et al.
Brain : a Journal of Neurology|August 6, 2024
Chloride deregulation and GABA depolarization in MTOR-related malformations of cortical developmentNaziha Bakouh, Reyes Castaño-Martín, Alice Metais, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2019
Germline <i>GPR161</i> Mutations Predispose to Pediatric MedulloblastomaMatthias Begemann, Sebastian M Waszak, Giles W Robinson, et al.
Brain Pathology (Zurich, Switzerland)|July 27, 2021
An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB-fused broadening the spectrum of tumor entities in comparison with their soft tissue counterpartsArnault Tauziède-Espariat, Philipp Sievers, Frédérique Larousserie, et al.
Pageof 25